PRINS
gene geneOn this page
Also known as NCRNA00074
Summary
PRINS (psoriasis associated non-protein coding RNA induced by stress, HGNC:34235) is a long non-coding RNA gene on chromosome 10p12.1.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34235 |
| Approved symbol | PRINS |
| Name | psoriasis associated non-protein coding RNA induced by stress |
| Location | 10p12.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | NCRNA00074 |
| Entrez | 100169750 |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 4)
- PRINS regulates G1P3, a gene with anti-apoptotic effects in keratinocytes. siRNA-mediated inhibition of PRINS gene resulted in altered cell morphology and gene expression alterations. (PMID:20377629)
- silencing has no effect on LPS-induced NF-kappaB activity in normal human keratinocytes and HaCaT cells (PMID:21750967)
- PRINS may play a role in the NPM-mediated cellular stress response in the skin. (PMID:23344029)
- PRINS directly binds to the mRNA of IL-6 through sequence specific binding and leads to the downregulation of IL-6 at mRNA and protein level. (PMID:28900430)
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | affects cotreatment, decreases expression | 1 |
| butyraldehyde | increases expression | 1 |
| versicolorin A | decreases expression | 1 |
| bisphenol S | affects cotreatment, decreases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Dietary Carbohydrates | increases expression | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | decreases expression, affects cotreatment | 1 |
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.